Search

Naxitamab was created at MSK and has received Breakthrough Therapy Designation from the FDA.

… Friday, September 28, 2018 Summary Naxitamab was created at MSK and has received Breakthrough Therapy Designation from the FDA for the treatment of patients with high-risk neuroblastoma. Neuroblastoma is a rare cancer of the nerve tissue that usually arises in the abdomen. It mainly affects young children

Scientists in all stages of their careers gathered recently to hear from Sharon Milgram speak about how attitudes and behaviors that can get in the way of a successful career.

… Tuesday, April 9, 2019 Summary At a recent event, GSK students and scientists from across MSK heard from Sharon Milgram about the importance of perseverance and positivity in a career in science. The Gerstner Sloan Kettering Graduate School of Biomedical Sciences (GSK) offers a range of resources to

In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by MSK, Weill Cornell Medicine, and The Rockefeller University identified a vulnerability that opens the door to new treatments.

… Thursday, February 20, 2025 In their effort to answer a decades-old biological question about how the hepatitis B virus (HBV) is able to establish infection of liver cells, research led by Memorial Sloan Kettering Cancer Center (MSK), Weill Cornell Medicine, and The Rockefeller University identified

Memorial Sloan Kettering Cancer Center (MSK) is proud to announce it has been named to the “Brands that Matter” list by Fast Company.

… Tuesday, October 26, 2021 Memorial Sloan Kettering Cancer Center (MSK) is proud to announce it has been named to the “ Brands that Matter ” list by  Fast Company . The inaugural list celebrates 95 global companies and non-profits that have achieved relevance through cultural impact and social engagement

Learn about new insights into endometrial cancer discovered by MSK experts, including why the growing rates of this cancer are even more dangerous for Black women.

… Tuesday, December 19, 2023 The numbers are stark and deeply troubling. Endometrial cancer — which develops in the lining of the uterus (womb) and is sometimes called uterine cancer — is on the rise in the U.S. In 1987, there were 35,000 cases annually. That number has nearly doubled in 2023 to more than

Learn why Black men should be especially mindful of prostate cancer risk.

… Friday, January 17, 2025 Cancer does not discriminate, except when it does.  Prostate cancer  takes a harsher toll on Black men than other American men. Black men are almost 70% more likely than white men to develop prostate cancer in their lifetime and twice as likely to die from the disease, according

Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo®) and ipilimumab (Yervoy®) significantly increased overall survival versus treatment with sunitinib (Sutent®) alone, according to new findings from researchers at Memorial Sloan Kettering Cancer Center (MSK) that were reported online today in the New England Journal of Medicine.

… Wednesday, March 21, 2018 Treating people with advanced metastatic kidney cancer using a combination of the immunotherapy drugs nivolumab (Opdivo ® ) and ipilimumab (Yervoy ® ) significantly increased overall survival versus treatment with sunitinib (Sutent ® ) alone, according to new findings from researchers

An FDA-approved drug used to treat leukemia can serve as a temporary off switch for CAR T cells, MSK scientists have found.

… Wednesday, July 3, 2019 Summary Researchers at Memorial Sloan Kettering and University Hospital in Würzburg, Germany, have identified a simple way to temporarily switch off CAR T cells with a commonly used drug. The approach could potentially help doctors limit the sometimes-severe side effects of this

According to a new study from Memorial Sloan Kettering published June 24 in Nature Medicine, patients in active cancer treatment who develop COVID-19 infection don’t fare any worse than other hospitalized patients. Researchers say their findings suggest that no one should delay cancer treatment because of concerns about the virus.

… Wednesday, June 24, 2020 Background Mini Kamboj, MD Mini Kamboj, MD Ying Taur, MD, PhD Ying Taur, MD, PhD The characterization of COVID-19 in patients with cancer remains limited in published studies and nationwide surveillance analyses. Reports from China and Italy have raised the possibility that patients

Read about a therapeutic vaccine that could potentially prevent certain pancreatic and colorectal cancers from returning.

… Monday, August 11, 2025 According to a study co-led by researchers at Memorial Sloan Kettering Cancer Center (MSK), a new vaccine shows encouraging early results as a potential “off-the-shelf” treatment for patients with  pancreatic  or  colorectal cancer . Unlike individualized cancer vaccines, which